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Abstract
Background: CD147 plays a critical role in the invasive and metastatic activity of hepatocellular
carcinoma (HCC) cells by stimulating the surrounding fibroblasts to express matrix
metalloproteinases (MMPs). Tumor cells adhesion to extracellular matrix (ECM) proteins is the
first step to the tumor metastasis. MMPs degrade the ECM to promote tumor metastasis. The aim
of this study is to investigate the effects of small interfering RNA (siRNA) against CD147 (si-
CD147) on hepatocellular carcinoma cells' (SMMC-7721) architecture and functions.
Methods: Flow cytometry and western blot assays were employed to detect the transfection
efficiency of si-CD147. Confocal microscopy was used to determine the effects of si-CD147 on
SMMC-7721 cells' cytoskeleton. Invasion assay, gelatin zymography and cell adhesion assay were
employed to investigate the effects of si-CD147 on SMMC-7721 cells' invasion, gelatinase
production and cell adhesive abilities. Western blot assay was utilized to detect the effects of si-
CD147 on focal adhesion kinase (FAK), vinculiln and mitogen-activated protein kinase (MAPK)
expression in SMMC-7721 cells.
Results: Downregulation of CD147 gene induced the alteration of SMMC-7721 cell cytoskeleton
including actin, microtubule and vimentin filaments, and inhibited gelatinase production and
expression, cells invasion, FAK and vinculin expression. si-CD147 also blocked SMMC-7721 cells
adhesion to collagen IV and phosphorylation level of SAPK/JNKs. SAPK/JNKs inhibitor SP600125
inhibited gelatinase production and expression.
Conclusion:  CD147 is required for normal tumor cell architecture and cell invasion.
Downregulation of CD147 affects HCC cell structure and function. Moreover, the alteration of cell
behavior may be related to SAPK/JNK Pathway. siRNA against CD147 may be a possible new
approach for HCC gene therapy.
Published: 11 October 2008
Journal of Experimental & Clinical Cancer Research 2008, 27:50 doi:10.1186/1756-9966-27-50
Received: 23 May 2008
Accepted: 11 October 2008
This article is available from: http://www.jeccr.com/content/27/1/50
© 2008 Qian et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
Page 2 of 14
(page number not for citation purposes)
Background
CD147 is a member of immunoglobulin (Ig) superfamily
that takes an essential role in several normal tissues but is
particularly enriched on the surface of malignant tumor
cells in vitro and in vivo [1]. CD147 stimulates production
of several matrix metalloproteinases (MMPs) by fibrob-
lasts and endothelial cells [2,3]. Gelatinase, including
MMP-2 and MMP-9, is one of the important MMPs and
has been proposed to participate in human tumor inva-
sion and metastasis. Other names for CD147 include
human basigin, extracellular matrix metalloproteinase
inducer (EMMPRIN), and human leukocyte activation-
associated M6 antigen [4]. Homologues in other species
include rat OX-47 antigen, mouse basigin or gp42 and
chicken HT7 molecules [5]. CD147 has been thought to
act outside the cell, primarily through MMPs, even though
CD147 has also been shown to interact with several differ-
ent molecules suggesting that at a molecular level it may
be multifunctional [6,7]. Lim et al [8] found that
EMMPRIN up-regulated MMP-1 mRNA expression, which
was dependent on tyrosine kinase activity. Our previous
studies have demonstrated that HAb18G/CD147 stimu-
lates fibroblast cells to produce elevated levels of several
MMPs, including MMP-1, MMP-2, and MMP-9, which are
well known for prompting invasion of hepatocellular car-
cinoma (HCC) cells and antisense RNA of HAb18G/
CD147 inhibited the invasion of HCC cells in vitro [9].
The expression of HAb18G/CD147 reduced the sensitivity
of the store-operated Ca2+  entry to NO/cGMP and
enhanced the metastatic potentials of HCC cells [10]. Our
previous work has identified 9 binding peptides by
screening a random 12-mer phage peptide library. The
roles of these peptides inhibiting HCC cell invasion,
adhesion and angiogenesis were analyzed [11-13].
Metastasis formation is a multistep process that requires
tumor cells to progress through many different stages
[14]. Proteolysis of the extracellular matrix (ECM), as well
as increased locomotion, leads to intravasation and dis-
semination of tumor cells. Experimental evidences have
shown that cancer cells are armed with an array of prote-
olytic enzymes that appear to be essential for the process
of cancer dissemination [15]. Tumor cell adhesion,
deformability, motility, and cell receptors also play
important roles in cancer invasion.
In all mammalian cells, the cytoskeleton is represented by
three types of filamentous structures, including actin
microfilaments (AFs), intermediate filaments (IFs), and
microtubules (MFs). The cytoskeleton is a dynamic cell's
internal filamentous network whose formation and
remodeling underlies the fundamental processes of cell
motility and shape determination. The cytoskeleton not
only has function in maintaining cell shape, also involves
in cell motility and mitosis [16]. Tumor cell motility is a
critical step in tumor invasion and metastasis. In particu-
lar, it is known that membrane-associated cytoskeletal
proteins are required for tumor cell movement and infil-
tration to surrounding tissue [17].
Vinculin, which is one kind of cytoskeletal proteins
involved in formation of the cytoplasmic scaffolding,
takes an important role in cell adhesion and migration by
providing the link between the actin cytoskeleton and the
transmembrane receptors, integrin and cadherin [18].
Vinculin can regulate the ability of cancer cells to move
away from tumors and spread cancer to other parts of the
body [19]. FAK is a critical regulator of cell adhesion and
migration and active FAK can recruit additional structural
and signaling molecules to contribute to the assembly of
focal adhesion complex [20,21].
The mitogen-activated protein kinase (MAPK) super-
family is composed of three major sets of kinases, namely,
the extracellular-receptor kinases (ERK), the stress-acti-
vated protein kinases/c-Jun N-terminal kinases (SAPK/
JNKs) and the p38 MAPKinases [22]. SAPK/JNKs are
members of the MAPK family and are activated by a vari-
ety of environmental stresses. SAPK signaling cascade is
involved in the regulation of many cellular processes and
the research has recently demonstrated a functional role
for SAPK in the suppression of metastases [23].
RNA interference (RNAi) technology has been rapidly
adopted for the discovery and validation of gene function
through the use of a sequence-specific short interfering
RNA (siRNA), which was originally identified as 21–23-
nucleotide double-stranded RNA (dsRNA) fragments,
generated by a cellular enzyme called Dicer [24]. The use
of RNAi is spreading rapidly to nearly every aspect of bio-
medical research. The gene silencing capability of RNAi is
being used to study individual gene's biological function
and role in biochemical pathways.
Our previous studies have showed that siRNA of CD147
inhibited HAb18G/CD147 expression in HCC cells by RT-
PCR and the inhibitory rate was more than 70% (the
results have been submitted). Recently, our results
showed that dsRNA targeted for CD147 inhibits MMP-2
secretion and FAK expression in HCC cell line FHCC98
[25]. The results of microarray results showed that down-
regulation of CD147 leads to some cytoskeletal genes
alteration (the results have been submitted).
Although many studies on CD147 functions have been
widely carried out, the mechanism of tumor metastasis
induced by CD147 is still not clear, especially in HCC. In
order to further explore the mechanism, we employed
RNAi method to study the effects of si-CD147 on HCC
cell cytoskeleton, cell invasion, cell adhesion, the expres-Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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sion of vinculin, FAK and MAPK. Our data indicated that
si-CD147 inhibited HCC cells' invasion, adhesion, gelati-
nase production and induced cytoskeleton alteration.
Methods
Cell Culture
Human HCC cell line SMMC-7721 was obtained from
China Centre for Type Culture Collection, Chinese Acad-
emy of Sciences. SMMC-7721 cells were grown in com-
plete RPMI 1640 culture medium (GIBCO™ Invitrogen
Corporation, Carlsbad, California) supplemented with
10% fetal calf serum (Hyclone, Utah, USA), 1% penicil-
lin/streptomycin, and 2% L-glutamine at 37°C in a
humidified atmosphere of 5% CO2.
siRNA synthesis and transfection
SiRNA designed to target CD147 (Sense Sequence: GGU-
UCUUCGUGA GUUCCUCtt, Antisense Sequence: GAG-
GAACUCACGA AGAACCtg) was synthesized by Ambion
Research Inc. As a negative control, we used stealth™ RNAi
negative control Hi-GC (12935-400) (Invitrogen Corpo-
ration, Carlsbad, California). SMMC-7721 cells were
trypsinized and added into 6-well dishes (Nunc Inc in
Denmark) (6 × 105 cells/well). Cells were cultured with
growth medium without antibiotics until the 90% conflu-
ent at the time of transfection. 5 μl siRNA (50 nmol/ml)
of CD147 and 6 μl lipofectAMINE 2000 (Invitrogen Cor-
poration, Carlsbad, California) was respectively added to
500 μl RMPI-1640 medium without serum. After the 5
min incubation, the diluted siRNA (250 pmol) of CD147
and lipofectamine 2000 were mixed gently and incubated
for 20 min at room temperature (RT) to allow complex
formation to occur. The RNAi-lipofectAMINE 2000 com-
plexes were added to each well containing cells and mixed
gently. The cells were incubated at 37°C in a humidified
atmosphere of 5% CO2 for 48 h.
Flow cytometric analysis of CD147 expression
After being transfected with si-CD147 or control siRNA
for 48 h, SMMC-7721 cells were collected and labeled
with anti-CD147 (BD Pharmingen, USA) for 1 h at RT.
Cells were washed three times and co-cultured with goat
anti-mouse IgG-FITC (1:100, KPL, Oklahoma, USA) at
4°C in dark for 30 min and subjected to flow cytometric
analysis using a FACSCalibur flow cytometer (BD Bio-
sciences, California, USA) and CellQuest software (BD
Biosciences, California, USA).
Western blot analysis of CD147, FAK, vinculin, MMP-2, 
MMP-9 Erk1/2, p38, and SAPK/JNK MAP kinases
SMMC-7721 cells (1.0 × 105/ml) transfected with si-
CD147 or control siRNA suspension were collected, and
centrifuged at 800 r/min. The cell pellets were collected
and resuspended in lysis buffer of 50 mmol/l Tris-HCl
(pH 8.0), 150 mmol/l NaCl, 0.02% azido sodium, 0.1%
SDS, 100 μg/ml PMSF (phenylmethyl sulfonylfluoride),
1% Triton X-100, 0.5% deoxycholic acid and protease
inhibitor for 10 min on the ice. The lysis solution was cen-
trifuged at 16000 g for 10 min at 4°C and the superna-
tants were collected, and the protein concentration was
detected with Lowery's method. Equal total protein loads
of 100 μg were loaded on the lanes of SDS-polyacrylamide
gel and separated by electrophoresis in a 5% acrylamide
stacking gel and an 8% acrylamide separating gel. Protein
marker as the molecular weight ladders was loaded at the
same time. The proteins then transferred to PVDF mem-
brane (Immobilon-P, Millipore, Bedford, MA, USA). After
being blocked with 5% (w/v) Odyssey blocking buffer (Li-
COR Bioscience), the blots were incubated for overnight
with antibodies directed against CD147 (BD Pharmin-
gen), FAK(Sigma Aldrich, America) and vinculin (Merck
Calbiochem) at 4°C. Blots were washed 5 min three times
with tris-buffered saline/0.1% Tween-20 and incubated
with IRDye™ 800-labeled secondary antibodies (Li-COR
Biosciences, Nebraska, USA) (1:5000) for 1 h and identi-
cal lysates were reprobed with a GAPDH antibody
(Chemicon International, Inc., California, USA) as a load-
ing control. The membranes were washed as above, and
the bands were scanned by Odyssey Infrared Imaging Sys-
tem (LI-COR Biosciences, Nebraska, USA). The expres-
sions of MMP-2, MMP-9, MAPK expression in SMMC-
7721 cells transfected with CD147 siRNA, and the effects
of SAPK/JNK inhibitor SP600125 (Beyotime Biotech,
China) on MMP-2 and MMP-9 expression in SMMC-7721
cells were also detected by using chemiluminescence
(Santa Cruz Biotechnology Inc) after 30 s-1 min expo-
sures. MAPK family antibody sampler kit and phospho-
MAPK family antibody sampler kit were purchased from
Cell Signaling Technology, and anti-MMP-2 and anti-
MMP-9 were from Merck Calbiochem.
Gelatin Zymography analysis of gelatinase production
After being transfected with si-CD147 or control siRNA
for 48 h, SMMC-7721 cells were continuously cultured for
15 h in serum-free RPMI 1640. The supernatants were col-
lected and centrifuged to remove debris. Conditioned
medium were separated by SDS-PAGE under nonreducing
conditions using 8% separating gel containing 0.1% gela-
tin. The gels were incubated in 2.5% Triton X-100 solu-
tion at room temperature with gentle agitation to remove
SDS and were soaked in reaction buffer 50 mM Tris-HCl
(pH 7.5), 200 mM NaCl, 10 mM CaCl2, at 37°C over-
night. After reaction, the gels were stained for 6 h with
staining solution and were destained about 0.5 h. Gelati-
nolytic activity of MMPs was visualized as a clear band
against a dark background of stained gelatin. The MMP-2
and MMP-9 production were also investigated after
SMMC-7721 cells were treated with SP600125 (100 μM)
for 1 h by gelatin zymography.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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Invasion assay
In vitro invasion assay was performed by using millicell
inserts (Millipore Corp) with polycarbonate filters (pore
size, 8 μm). The upper side of polycarbonate filter was
coated with matrigel (0.6 mg/ml, BD Biosciences) to form
a continuous thin layer. Prior to the addition of cell sus-
pension, the dried layer of matrigel matrix was rehydrated
with medium without serum for 2 h at RT. The Cells trans-
fected with si-CD147 or control siRNA were harvested and
2.2 × 105 cells in 300 μl of 0.1% serum-medium were
placed in the upper chamber. The lower chamber was
filled with 0.1% serum-medium (200 μl) and serum-free
conditioned medium from NIH/3T3 (300 μl). Cells were
cultured for 24 h at 37°C in 5% CO2. After incubation, the
cells were washed three times with RPMI and were then
fixed by immersing the chambers in 95% methanol for 10
mins. Cells on the upper surface were removed with a cot-
ton swab and were stained with hematoxylin and eosin.
Cells migrated on the underside of the membrane were
counted microscopically. The determinations were done
in triplicate.
Cell adhesion assay
SMMC-7721 cells (5 × 104) transfected with si-CD147 or
control siRNA were suspended and added in 96-well
micro-plates coated with fibronectin (FN), laminin (LN),
and collagen IV (3 μg per well, BD Biosciences). The cells
were allowed to adhere for 60 min at 37°C. The wells were
washed three times with PBS and the cells were fixed with
4% formaldehyde. The cells were then stained with 0.5%
crystal violet in 20% (v/v) methanol/water and viewed
under a microscope. The amount of bound cells was esti-
mated by solubilizing the dye using 0.1 M sodium citrate
and reading the absorbance at 490 nm. Triplicate determi-
nations were done at each data point.
Confocal microscopy
Cells transfected si-CD147 or control siRNA for 48 h were
collected and added to the sterile coverslips and cultured
overnight. The cells were washed twice with pre-warmed
phosphate-buffered saline (PBS), pH 7.4. For antibodies
that have unknown properties on fixed cells it is best to
start with one fixing condition that preserves native struc-
ture, so we chose different fixative dependent on different
aims. We chose -20°C methanol for 1–2.5 minutes to fix
cells for actin filaments. 0.5% glutaraldehyde fixation was
chose for tubulin and vimentin filaments. Then the fixed
cells were washed with TBS and blocked with 2% BSA in
TBS-0.1% TX for 10 mins. Anti-actin (Sigma Aldrich,
America), Anti-tubulin (Merck Calbiochem) and anti-
vimentin (Merck Calbiochem) were added to the fixed
cells for 4°C overnight and then sheep anti mouse FITC-
IgG (1:100, KPL, Oklahoma, USA) was added for 60 mins
at RT in dark. The cells were washed for three times with
TBS, enveloped with glycerol, and then observed by con-
focal microscope (Leika DMIRE2/TCS SP2).
Statistical analysis
Statistically significant differences were determined Prism
statistical soft (GraphPad Software). P < 0.05 was consid-
ered significant in all cases.
Results
SiRNA against CD147 inhibits CD147 expression in 
SMMC-7721 cells
Our previous results suggested that CD147 was highly
expressed in HCC cells [9]. To analyze whether siRNA
against CD147 could specifically inhibited CD147 expres-
sion, we used flow cytometric analysis and western blot
assay to determine the effects of si-CD147 on CD147
expression in SMMC-7721 cells. The results showed that
the expression of CD147 in SMMC-7721 cells transfected
with si-CD147 was significantly decreased with an inhib-
itory rate over 80% compared with that in negative con-
trol cells (Figure. 1).
Downregulation of CD147 inhibits MMP-2 and MMP-9 
expression in SMMC-7721 cells
To investigate whether the downregulation of CD147 in
SMMC-7721 affects MMPs secretion, we evaluated MMP-
2 and MMP-9 expression in SMMC-7721 cells transfected
with si-CD147 by gelatin zymography and western blot
assay. Gelatin zymograpy analysis showed that MMP-2
production in SMMC-7721 cells transfected with si-
CD147 was decreased by over 50% compared with that in
negative control cells (Figure. 2A and 2B). Western blot
analysis showed that both of the MMP-2 and MMP-9
expression were inhibited in SMMC-7721 cells transfected
with si-CD147 compared with that in control cells (Fig-
ure. 2C, 2D and 2E).
Downregulation of CD147 gene blocks SMMC-7721 cells' 
invasion
In order to confirm whether CD147 is involved in the
process of cell motility, we used invasion assay to deter-
mine the impact of siRNA-CD147 on SMMC-7721 cells'
invasion. 5 × 105 cells transfected with si-CD147 or con-
trol siRNA were added to millicell inserts coated with
matrigel. We observed that the number of infiltrating cells
was significantly decreased in SMMC-7721 cells trans-
fected with si-CD147 compared with that in control cells
and the inhibitory rate was about 85% (Figure. 3A and
3B).
Downregulation of CD147 inhibited SMMC-7721 cells 
adhesion to collagen IV
The effects of si-CD147 on the adhesive abilities of HCC
cells to ECM proteins including FN, LN and collagne IV
were detected by adhesion assays. The results indicatedJournal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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that si-CD147 inhibited SMMC-7721 adhesion to colla-
gen IV but had no effects on SMMC-7721 cells adhesion
to FN and LN (Figure. 4).
Downregulation of CD147 results in the cytoskeletal 
alteration of SMMC-7721 cells
We examined the effects of siRNA-mediated CD147 gene
silencing on SMMC-7721 cytoskeleton including actin fil-
ament, microtubule and intermediate filament by confo-
cal microscopy. SMMC-7721 cells transfected with si-
CD147 or control siRNA were labeled respectively with
antibodies targeting actin, tublulin and vimentin to visu-
alize these protein. In SMMC-7721 cells transfected with
si-CD147, actin showed a nuclear concentration and
decreased fluorescence intensity. (Figure. 5). The microtu-
bule constructed to a network and cells appeared flattened
in si-CD147 transfected cells, but the difference of fluores-
cence intensity between two groups was not significant
(Figure. 5). Vimentin filaments showed an interlaced pat-
tern in control cells but in transfected cells they seemed to
form foci in the periphery of cells, and the difference of
fluorescence intensity between two groups was not signif-
icant (Figure. 5).
Downregulation of CD147 inhibits FAK and Vinculin 
expression in SMMC-7721 cells
In order to further investigate whether CD147 is involved
in signal transduction, we tested FAK and vinculin expres-
sion in SMMC-7721 cells transfected with si-CD147 by
western blot. The results showed that si-CD47 signifi-
cantly inhibited vinculin and FAK expression (Figure. 6A
CD147 expression in SMMC-7721 cells transfected with negative control siRNA or siRNA-CD147 Figure 1
CD147 expression in SMMC-7721 cells transfected with negative control siRNA or siRNA-CD147. After SMMC-
7721 being transfected with negative control siRNA or si-CD147 for 48 h, CD147 expression was detected using flow cytom-
etry (A, B) and western blot assay(C, D). GAPDH as a loading control was shown in the bottom panel. The PVDF membranes 
were washed and the bands were scanned by Odyssey Infrared Imaging System (C). The graph (D) compares scanning signal 
intensity of CD147 by ImageJ software.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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and 6B).
siRNA of CD147 inhibits phosphorylation of SAPK/JNK but 
not other MAP kinases
MAPK pathway plays an important role in regulating
MMPs production, cell motility and invasion, so we detect
the effects of si-CD147 on MAPK. The results showed that
si-CD147 inhibited phosphorylation of SAPK/JNK. No
decreased signal was detected with the phospho-Erk/p44/
p42 and phospho-ERK1/2 antibodies (Figure. 7). In addi-
tion, si-CD147 had no effects on nonphophorylation of
MAPK (Figure. 7).
SAPK/JNK inhibitor SP600125 blocks gelatinase 
production and expression
In order to identify whether the production and expres-
sion of MMP-2 and MMP-9 are related to SAPK/JNK, we
examined the effects of SAPK/JNK inhibitor SP600125 on
MMP-2 an MMP-9 by gelatin zymography and western
blot assay. The results showed that MMP-2 production
was significantly reduced in SMMC-7721 cells treated by
SP600125 (Figure 8A and 8B). SAPK/JNK inhibitor
SP600125 also inhibited the expression of MMP-2 and
MMP-9 in SMMC-7721 cells (Figure. 8C–F).
Discussion
The primary mechanism of cell motility is related to reor-
ganization of the actin cytoskeleton. Thus, a potentiality
of regulating tumor cell invasion and metastasis by con-
trolling actin cytoskeleton to control cell migration has
been provided. Although there are many factors to regu-
late cell motility, the bundling and subcellular distribu-
tion of the actin cytoskeleton directly determines cell
motility [26].
In this study the siRNA targeted CD147 was designed and
synthesized and the effects of si-CD147 on SMMC-7721
cell's invasive abilities and cytoskeleton were investigated.
Our findings showed that si-CD147 induced SMMC-7721
cytoskeleton alteration including actin, tubulin and
Detection of the effects of si-CD147 on gelatinase production by gelatin zymography (A, B) and western blot assay (C, D, E) Figure 2
Detection of the effects of si-CD147 on gelatinase production by gelatin zymography (A, B) and western blot 
assay (C, D, E). The production and expression of gelatinase were detected by gelatin zymography (A, B) and western blot 
assay (C, D, E), after SMMC-7721 cells were treated with si-CD147 or negative control siRNA for 48 h. MMP-2 production 
was decreased significantly in SMMC-7721 cells transfected with si-CD147 (A). The graph (B) compares scanning signal inten-
sity of MMP-2 by ImageJ software. MMP-2 and MMP-9 expression greatly decreased in SMMC-7721 cells transfected with si-
CD147 (C). The graph (D, E) compares scanning signal intensity of MMP-9 and MMP-2 expression by ImageJ software.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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viment filaments. Recently, in our lab the results of micro-
array results showed that downregulation of CD147 leads
to some cytoskeletal genes alteration, such as vimentin
gene is upreglated more than twice in hepatocellar carci-
noma cells transfected si-CD147 (data not shown). Tsai
WC [27] showed that actin and vimentin expression in
breast phyllodes tumors correlates with tumor grades of
the WHO grading system. Recent reports have reported
the expression of vimentin in numerous neoplasms,
including melanoma, which has been linked to metastatic
disease [28]. It has been reported by the University of
Iowa Health Care research group and by others that the
co-expression of vimentin along with keratins in human
melanoma is associated with recurrent and metastatic dis-
ease [29]. Khunkeawla et al [30] studied that U937 cell
aggregation induced by CD147 mAbs is associated with
cytoskeleton reorganization and the results showed that
cell aggregation induced by the engagement of CD147
with specific mAbs depended upon the activation of pro-
tein kinases and a functional cytoskeleton. Together with
the recent findings that antibodies to CD147 also neutral-
ize cell aggregation mediated by CD98 [31], it may be
speculated that CD147 plays a central role in cellular
events associated with cytoskeleton rearrangement. Cur-
tin et al [32] showed that D-basigin is necessary for cell to
maintain normal architecture. D-basigin (EMMPRIN/
Effects of si-CD147 RNA on SMMC-7721 cells' invasive abilities Figure 3
Effects of si-CD147 RNA on SMMC-7721 cells' invasive abilities. The invasive abilities of SMMC-7721 cells transfected 
with negative control and si-CD147 RNA were examined by chamber assay. HE staining and quantitative analysis were 
employed to analyze the number of the transmembrane cells. Transmembrane cells number dramatically reduced in SMMC-
7721 cells transfected with si-CD147 (A). The graph (B) compares the number of transmembrane cells and indicates an 85% 
inhibition by si-CD147. ***P < 0.001 v.s. control.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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CD147) interacts with integrin to affect cellular architec-
ture and D-basigin partially colocalizes with actin in High
Five cells. Schlosshauer, et al [33] was also previously
reported that D-basigin partially colocalizes with actin in
chick retinal pigment epithelium.
Tumor cell invasion and adhesion are very critical steps in
tumor metastasis. In this study, the invasive abilities of
SMMC-7721 cells were inhibited by si-CD147. The results
further confirm that CD147 plays critical roles in tumor
cell invasion. Wang, et al [34] showed that downregula-
tion of CD147 by RNAi decreased the invasive capability
of prostate cancer cells. Tumor cell metastasis involves a
complex series of interdependent events, including
repeated invasion of basement membranes (BM) [35].
The major component of the BM is known to be collagen
IV. The results showed that si-CD147 inhibited SMMC-
7721 cells adhesion to collagen IV but not FN and LN.
This suggests that si-CD147 may inhibit specific receptors
of collagen IV. Two specific receptor molecules of collagen
IV, α1β1 and α2β1 have been identified. Integrin α1β1
and α2β1 are the key regulators of hepatocarcinoma cell
invasion across the fibrotic matrix microenvironment
[36].
Vinculin is a highly conserved cytoskeletal protein that is
essential for regulation of cell morphology and migration,
and is a critical component of both cell-cell and cell-
Effects of si-CD147RNA on SMMC-7721 cells adhesion to fibronectin, collagen IV and laminin Figure 4
Effects of si-CD147RNA on SMMC-7721 cells adhesion to fibronectin, collagen IV and laminin. SMMC-7721 cells 
(5 × 104) transfected with negative control or si-CD147 were added to 96-well micro-plates coated with FN, LN, and collagen 
IV. The cells were allowed to adhere for 60 min at 37°C and were then stained with 0.5% crystal violet in 20% (v/v) methanol/
water. The amount of bound cells was estimated by solubilizing the dye using 0.1 M sodium citrate and reading the absorbance 
at 490 nm. The results indicated that si-CD147 inhibited SMMC-7721 adhesion to collagen IV but had no effects on adhesion to 
FN and LN. *P < 0.05 v.s. control.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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The effects of si-CD147 on SMMC-7721 microfilament actin, microtubule and vimentin Figure 5
The effects of si-CD147 on SMMC-7721 microfilament actin, microtubule and vimentin. After being transfected 
with negative control or si-CD147 for 48 h, cells were trypsinized and cultured on coverslips, and then fixed. The effects of si-
CD147 on SMMC-7721 cytoskeleton were investigated by confocal microscopy. Actin, mirotublin and vimentin filaments in si-
CD147 transfected cells were significantly altered (A) and the mean signal intensities were quantified with ImageJ software (B). 
*P < 0.05 v.s. control.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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matrix complexes [37]. The results of this study showed
that si-CD147 inhibited vinculin expression. It indicates
the decrease of vinculin expression maybe affects both
cell-cell and cell-matrix complexes formation and finally
influences SMMC-7721 cell motility and adhesion.
Kuroda, et al, has reported that vinculin may serve as a
useful marker of renal neoplasms with collecting duct sys-
tem phenotype such as chromophobe-type renal cell car-
cinomas [38].
Focal adhesion formation is an essential step in cell adhe-
sion [39]. Our data also showed that si-CD147 inhibited
FAK expression in SMMC-7721. A number of reports have
showed that Elevated FAK expression has been linked to
the increased invasive potential of human tumors [40,41].
Lu, et al has reported that downregulation of FAK activity
might be essential and required for early metastatic
spreading, enabling vascular circulation of tumor cells
without adhesion. Once tumor cells reattach to the ECM,
integrin stimulation of FAK promotes adhesion and the
growth of a metastatic tumor [42].
SAPKs/JNKs function in a protein kinase cascade trans-
ducing cellular stress signals and are activated by a highly
diverse group of extracellular signals [43]. Simon, et al
[44] showed that SAPK pathway regulates the expression
of the MMP-9 collagenase via AP-1-dependent promoter
activation. Our results showed that siRNA of CD147
inhibited phosphorylation of SAPK/JNK. It suggests that
tyrosine phosphorylation-dependent MAP kinases SAPK/
JNK but not ERK 1/2 and p38 kinases control the response
to CD147. Moreover, SAPK/JNK specific inhibitor
SP600125 blocked gelatinase expression and production,
so it indicated that SAPK/JNK maybe participated in regu-
lating gelatinase production.
Lim, et al [8] studied that EMMPRIN-mediated stimula-
tion of MMP-1 synthesis in human lung fibroblasts is
Effects of si-CD147 on FAK and vinculin expression in SMMC-7721 cells Figure 6
Effects of si-CD147 on FAK and vinculin expression in SMMC-7721 cells. Total cellular protein from SMMC-7721 
cells tranfected with siRNA was analyzed by 10% SDS-PAGE and transferred to PVDF membrane prior to immunoblotting. The 
PVDF membranes were washed and the bands were scanned by Odyssey Infrared Imaging System. The results showed that si-
CD147 inhibited FAK and vinculiln expression in SMMC-7721 cells (A). The graph (B) compares scanning signal intensity of 
FAK and vinculin expression by ImageJ software.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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dependent on the activity of the MAP kinase, p38, but not
ERK1/2 or SAPK/JNK. Si-CD147 inhibits phosphorylation
of SAPK/JNK, which further confirms that gelatinase
expression induced by CD147 depends on SAPK/JNK
pathway. Our previous findings indicated that siRNA tar-
geted against HAb18G/CD147 inhibits ERK1/2 pathway
in HCC cell line FHCC98 [25]. The disparity may be
related to different siRNA sequence and different cell
lines, and the further mechanism is under study.
Conclusion
CD147 is required for normal tumor cell architecture and
cell invasion. siRNA targeted to CD147 inhibited HCC
cell invasion, adhesion to Collagen IV and gelatinase pro-
Effects of si-CD147 on MAPK expression in SMMC-7721 cells Figure 7
Effects of si-CD147 on MAPK expression in SMMC-7721 cells. p38, ERK1/2, and JNK MAP kinase expression levels 
were analyzed in SMMC-7721 cells, respectively. Western blot analysis showed that si-CD147 inhibited the phosphorylation 
level of SAP/JNK but had no effects on non-phosphorylation level of SAP/JNK (A). GAPDH (lower panel) served as a loading 
control. The graph (B) compares scanning signal intensity of phos-SAPK and non-phos-SAPK expression by ImageJ software.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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Effects of SAPK/JNK inhibitor SP600125 on gelatinase production and expression Figure 8
Effects of SAPK/JNK inhibitor SP600125 on gelatinase production and expression. Total cellular protein from 
SMMC-7721 cells treated with SP600125(100 μM) for 1 h was analyzed by gelatin zymography and western blot assay. The 
results showed that MMP-2 production (A) and expression (C), and MMP-9 expression (E) in SMMC-7721 cells treated with 
SP600125 was significantly inhibited. The graph (B, D, F) compares scanning signal intensity of MMP-2 and MMP-9 production 
and expression by ImageJ software.Journal of Experimental & Clinical Cancer Research 2008, 27:50 http://www.jeccr.com/content/27/1/50
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duction, and affected cytoskeleton structure. Moreover,
the inhibition of gelatinase production may be related to
the downregulation of phosphorylation-dependent
SAPK/JNK.
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